IRIS Accounts Production v24.1.9.2 03698954 Board of Directors 1.11.22 31.10.23 31.10.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh036989542022-10-31036989542023-10-31036989542022-11-012023-10-31036989542021-10-31036989542021-11-012022-10-31036989542022-10-3103698954ns15:EnglandWales2022-11-012023-10-3103698954ns14:PoundSterling2022-11-012023-10-3103698954ns10:Director12022-11-012023-10-3103698954ns10:PrivateLimitedCompanyLtd2022-11-012023-10-3103698954ns10:SmallEntities2022-11-012023-10-3103698954ns10:AuditExempt-NoAccountantsReport2022-11-012023-10-3103698954ns10:SmallCompaniesRegimeForDirectorsReport2022-11-012023-10-3103698954ns10:SmallCompaniesRegimeForAccounts2022-11-012023-10-3103698954ns10:FullAccounts2022-11-012023-10-3103698954ns10:Director22022-11-012023-10-3103698954ns10:CompanySecretary12022-11-012023-10-3103698954ns10:RegisteredOffice2022-11-012023-10-3103698954ns5:CurrentFinancialInstruments2023-10-3103698954ns5:CurrentFinancialInstruments2022-10-3103698954ns5:ShareCapital2023-10-3103698954ns5:ShareCapital2022-10-3103698954ns5:RetainedEarningsAccumulatedLosses2023-10-3103698954ns5:RetainedEarningsAccumulatedLosses2022-10-3103698954ns5:LeaseholdImprovements2022-11-012023-10-3103698954ns5:PlantMachinery2022-11-012023-10-3103698954ns5:FurnitureFittings2022-11-012023-10-3103698954ns5:MotorVehicles2022-11-012023-10-3103698954ns5:ComputerEquipment2022-11-012023-10-3103698954ns5:LeaseholdImprovements2022-10-3103698954ns5:PlantMachinery2022-10-3103698954ns5:FurnitureFittings2022-10-3103698954ns5:LeaseholdImprovements2023-10-3103698954ns5:PlantMachinery2023-10-3103698954ns5:FurnitureFittings2023-10-3103698954ns5:LeaseholdImprovements2022-10-3103698954ns5:PlantMachinery2022-10-3103698954ns5:FurnitureFittings2022-10-3103698954ns5:MotorVehicles2022-10-3103698954ns5:ComputerEquipment2022-10-3103698954ns5:MotorVehicles2023-10-3103698954ns5:ComputerEquipment2023-10-3103698954ns5:MotorVehicles2022-10-3103698954ns5:ComputerEquipment2022-10-3103698954ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-10-3103698954ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-10-3103698954ns5:DeferredTaxation2022-10-3103698954ns5:DeferredTaxation2023-10-31036989541ns10:Director12022-10-31036989541ns10:Director12021-10-31036989541ns10:Director12022-11-012023-10-31036989541ns10:Director12021-11-012022-10-31036989541ns10:Director12023-10-31036989541ns10:Director12022-10-31
REGISTERED NUMBER: 03698954 (England and Wales)










A & M PHARMACIES LIMITED

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 OCTOBER 2023






A & M PHARMACIES LIMITED (REGISTERED NUMBER: 03698954)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


A & M PHARMACIES LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 OCTOBER 2023







DIRECTORS: Mr A L Hindocha
Mrs M A Hindocha





SECRETARY: Mrs M A Hindocha





REGISTERED OFFICE: 126 Sutherland Avenue
Coventry
West Midlands
CV5 7NJ





REGISTERED NUMBER: 03698954 (England and Wales)





ACCOUNTANTS: Shah & Co (Accountants) Ltd
Chartered Certified Accountants
Cash's Business Centre
1st Floor
228 Widdrington Road
Coventry
West Midlands
CV1 4PB

A & M PHARMACIES LIMITED (REGISTERED NUMBER: 03698954)

BALANCE SHEET
31 OCTOBER 2023

31.10.23 31.10.22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 118,045 121,502

CURRENT ASSETS
Stocks 167,847 94,181
Debtors 5 444,840 926,980
Cash at bank and in hand 311,339 492,281
924,026 1,513,442
CREDITORS
Amounts falling due within one year 6 374,416 376,202
NET CURRENT ASSETS 549,610 1,137,240
TOTAL ASSETS LESS CURRENT
LIABILITIES

667,655

1,258,742

PROVISIONS FOR LIABILITIES 7 13,274 10,210
NET ASSETS 654,381 1,248,532

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 654,281 1,248,432
SHAREHOLDERS' FUNDS 654,381 1,248,532

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 October 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 October 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

A & M PHARMACIES LIMITED (REGISTERED NUMBER: 03698954)

BALANCE SHEET - continued
31 OCTOBER 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 30 July 2024 and were signed on its behalf by:





Mr A L Hindocha - Director


A & M PHARMACIES LIMITED (REGISTERED NUMBER: 03698954)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2023

1. STATUTORY INFORMATION

A & M Pharmacies Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Improvements to property - 15% on reducing balance
Plant and machinery - 15% on reducing balance
Fixtures and fittings - 15% on reducing balance
Motor vehicles - 25% on reducing balance
Computer equipment - 15% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

A & M PHARMACIES LIMITED (REGISTERED NUMBER: 03698954)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 OCTOBER 2023

2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 33 (2022 - 33 ) .

4. TANGIBLE FIXED ASSETS
Improvements Fixtures
to Plant and and
property machinery fittings
£    £    £   
COST
At 1 November 2022 318,688 58,355 460,662
Additions - - -
At 31 October 2023 318,688 58,355 460,662
DEPRECIATION
At 1 November 2022 271,347 42,999 414,950
Charge for year 7,101 2,303 6,857
At 31 October 2023 278,448 45,302 421,807
NET BOOK VALUE
At 31 October 2023 40,240 13,053 38,855
At 31 October 2022 47,341 15,356 45,712

Motor Computer
vehicles equipment Totals
£    £    £   
COST
At 1 November 2022 7,990 69,533 915,228
Additions 7,140 11,212 18,352
At 31 October 2023 15,130 80,745 933,580
DEPRECIATION
At 1 November 2022 6,813 57,617 793,726
Charge for year 2,079 3,469 21,809
At 31 October 2023 8,892 61,086 815,535
NET BOOK VALUE
At 31 October 2023 6,238 19,659 118,045
At 31 October 2022 1,177 11,916 121,502

A & M PHARMACIES LIMITED (REGISTERED NUMBER: 03698954)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 OCTOBER 2023

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.10.23 31.10.22
£    £   
Trade debtors 20,075 33,975
Other debtors 424,765 893,005
444,840 926,980

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.10.23 31.10.22
£    £   
Trade creditors 277,501 301,305
Taxation and social security 36,507 41,409
Other creditors 60,408 33,488
374,416 376,202

7. PROVISIONS FOR LIABILITIES
31.10.23 31.10.22
£    £   
Deferred tax 13,274 10,210

Deferred
tax
£   
Balance at 1 November 2022 10,210
Increase in provision 3,064
Balance at 31 October 2023 13,274

8. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 October 2023 and 31 October 2022:

31.10.23 31.10.22
£    £   
Mr A L Hindocha
Balance outstanding at start of year - -
Amounts advanced 130,000 -
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 130,000 -

During the year rent was paid to the directors Mr. & Mrs. A Hindocha on normal commercial terms. The rent was for the premises at Mount Nod in Coventry, the amounts paid were £15,000 (2022- £15,000).

Included within the creditors , the amount owed to the directors is £ 3,365 (2022 £ 19,742 ).These loans are interest free and with no fixed date of repayment.

9. RELATED PARTY DISCLOSURES

During the year, total dividends of £50,000 (2022 - £40,000) were paid to the directors .

A & M PHARMACIES LIMITED (REGISTERED NUMBER: 03698954)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 OCTOBER 2023

10. ULTIMATE CONTROLLING PARTY

The controlling party is Mr & Mrs Hindocha.